Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBCAS: Butylphthalide for dCA in Acute Ischemic Stroke
NCT03413202Phase 4Completed
- Start
- Feb 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of butylphthalide in ischemic stroke. Started Feb 2018; status: completed.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03413202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413202.